(Q53094070)

English

Assessment of the clinical application of detecting EGFR, KRAS, PIK3CA and BRAF mutations in patients with non-small cell lung cancer using next-generation sequencing.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

Assessment of the clinical application of detecting EGFR, KRAS, PIK3CA and BRAF mutations in patients with non-small cell lung cancer using next-generation sequencing. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

author name string

Xinnan Xu

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

Yang Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

Hui Li

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

Zhao Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

Gening Jiang

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

Ke Fei

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

publication date

23 May 2016

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

Scandinavian Journal of Clinical and Laboratory Investigation

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

76

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

386-392

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

describes a project that uses

massive parallel sequencing

1 reference

based on heuristic

inferred from title

Global cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Poor prognosis patients with inoperable locally advanced NSCLC and large tumors benefit from palliative chemoradiotherapy: a subset analysis from a randomized clinical phase III trial

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: a retrospective analysis in Korea

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Epidermal growth factor receptor mutations in lung cancer

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

KRAS mutations in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Rapid detection of epidermal growth factor receptor mutations in non-small cell lung cancer using real-time polymerase chain reaction with TaqMan-MGB probes

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Clinical next-generation sequencing in patients with non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Advances in understanding cancer genomes through second-generation sequencing

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Exome sequencing identifies the cause of a mendelian disorder

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Targeted capture and massively parallel sequencing of 12 human exomes

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Transcriptome sequencing to detect gene fusions in cancer

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Chimeric transcript discovery by paired-end transcriptome sequencing

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Cancer genome landscapes

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Mutant allele frequency predicts the efficacy of EGFR-TKIs in lung adenocarcinoma harboring the L858R mutation.

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Performance comparison of benchtop high-throughput sequencing platforms

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1183813

21 January 2018

Identifiers

10.1080/00365513.2016.1183813

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27215271

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53094070&oldid=1878911507"